ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

LeafyRX Launches A New Telemedicine Platform To Assist With Medical Marijuana Card Certification

LeafyRX has launched a new HIPAA-compliant telemedicine platform for medical marijuana card certification, offering fast online evaluations, licensed doctors, and personalized treatment plans. Patients can schedule convenient virtual appointments and receive secure approvals, making access to legal medical cannabis simpler and faster.

-- LeafyRX has just launched a new method for patients to obtain medical marijuana cards online. Their new telemedicine platform helps patients access fast, professional online evaluations and streamlined approval processes. The platform connects them directly with licensed healthcare providers, providing convenient access to legal medical cannabis tailored to the individual needs of the patient.

The newly launched website allows users to book their appointment online and schedule their medical card certification and evaluation from the comfort of their own home. The platform then connects the patient with the right doctor based on the most convenient time as well as the State, with options for them to chat on a smartphone, computer, or tablet via phone call or video call. From there, depending on the state, after the registration is approved, they will email the patient a downloadable patient ID card they can print or send by mail.

LeafyRX aims to provide a safe and secure platform for those looking to access the healthcare they need, while following strict guidelines in keeping with HIPAA compliance. Their team vets board-certified doctors across the US to provide the highest quality and best-matched resources, including those with specialized knowledge on a range of conditions who are able to create customized treatment plans to suit the needs of each individual patient.

As well as ensuring that patients meet all the legal requirements to receive their medical card, they are able to provide continuous follow-ups to make sure that any treatment plan continues to meet their needs. The doctors are able to provide personalized advice, helping the patient get the care that meets their specific medical needs.

While security and high-quality medical services are the highest priority for LeafyRX, they also aim to provide a more convenient and timely service, especially for those who may not be able to physically attend appointments in their area as easily. As such, they have an easy online application form, aiming to create a fast and stress-free experience, and most applications made through their telemedicine platform are processed within 24-48 hours.

Those who want to learn about whether they could apply for a medical marijuana card or have questions on the process can also take a look at the FAQ section on the website, which aims to clarify a host of common concerns.

For more information about LeafyRX, use the contact details below:

Contact Info:
Name: Ellen Ernst
Email: Send Email
Organization: LeafyRX
Address: 131 Continental Drive, Suite 301, Newark, New Castle 19713-4323, United States
Phone: +14153252681
Website: https://leafyrx.org/

Release ID: 89169430

In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.